ICD1845K ;ALB/MJB - FY 2010 DRG UPDATE ; 11/1/07 11:35am
 ;;18.0;DRG Grouper;**45**;Oct 13, 2000;Build 14
 ;
 Q
 ;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS^
 ;;810^16^MED^MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W/O CC/MCC^0.8689^3.1^3.9
 ;;811^16^MED^RED BLOOD CELL DISORDERS W MCC^1.2431^3.9^5.4
 ;;812^16^MED^RED BLOOD CELL DISORDERS W/O MCC^0.7751^2.8^3.7
 ;;813^16^MED^COAGULATION DISORDERS^1.3846^3.7^5.2
 ;;814^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W MCC^1.5144^5.1^6.8
 ;;815^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W CC^0.9596^3.6^4.6
 ;;816^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W/O CC/MCC^0.6953^2.7^3.4
 ;;820^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W MCC^5.3673^12.8^16.8
 ;;821^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W CC^2.2672^5.2^7.5
 ;;822^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W/O CC/MCC^1.1632^2.4^3.3
 ;;823^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W MCC^3.901^11.5^14.8
 ;;824^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W CC^2.152^6.3^8.6
 ;;825^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W/O CC/MCC^1.2003^2.9^4.1
 ;;826^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W MCC^4.5104^11.7^14.9
 ;;827^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W CC^2.0111^5.2^6.9
 ;;828^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W/O CC/MCC^1.2384^2.8^3.5
 ;;829^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W CC/MCC^2.6088^6.4^9.6
 ;;830^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W/O CC/MCC^0.9784^2.3^3.1
 ;;834^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W MCC^4.3709^9.3^15.1
 ;;835^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W CC^2.4817^5.9^9.7
 ;;836^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W/O CC/MCC^1.2595^3.2^4.9
 ;;837^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX OR W HIGH DOSE CHEMO AGENT W MCC^6.3616^18.1^23.4
 ;;838^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W CC OR HIGH DOSE CHEMO AGENT^3.0949^8.5^12.9
 ;;839^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W/O CC/MCC^1.2496^4.8^5.9
 ;;840^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W MCC^2.7258^7.7^10.5
 ;;841^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W CC^1.5071^5^6.7
 ;;842^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W/O CC/MCC^0.9803^3.2^4.3
 ;;843^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W MCC^1.6852^5.9^7.9
 ;;844^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W CC^1.1997^4.5^6
 ;;845^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC^0.8043^3.1^4.1
 ;;846^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W MCC^2.1717^6^8.5
 ;;847^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC^0.9451^2.7^3.4
 ;;848^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC^0.8235^2.5^3.2
 ;;849^17^MED^RADIOTHERAPY^1.2837^4.4^6.2
 ;;853^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W MCC^5.4946^12.5^16.3
 ;;854^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W CC^2.729^8.8^10.8
 ;;855^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W/O CC/MCC^1.704^5.5^7.3
 ;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W MCC^4.9249^11.4^15.5
 ;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W CC^2.0439^6.3^8.1
 ;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W/O CC/MCC^1.3521^4.4^5.5
 ;;862^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W MCC^1.9008^6^8
 ;;863^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W/O MCC^0.9702^4.1^5.1
 ;;864^18^MED^FEVER^0.8153^3.1^3.9
 ;;865^18^MED^VIRAL ILLNESS W MCC^1.3601^4.4^6.2
 ;;866^18^MED^VIRAL ILLNESS W/O MCC^0.6736^2.8^3.5
 ;;867^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W MCC^2.3705^6.9^9.4
 ;;868^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W CC^1.068^4.2^5.4
 ;;869^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC^0.7419^3.3^4.1
 ;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS W MV 96+ HOURS^5.8007^12.9^15.5
 ;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV 96+ HOURS W MCC^1.8437^5.4^7.3
 ;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV 96+ HOURS W/O MCC^1.1155^4.6^5.6
 ;;876^19^SURG^O.R. PROCEDURE W PRINCIPAL DIAGNOSES OF MENTAL ILLNESS^2.5892^8^13.1
 ;;880^19^MED^ACUTE ADJUSTMENT REACTION & PSYCHOSOCIAL DYSFUNCTION^0.6191^2.4^3.2
 ;;881^19^MED^DEPRESSIVE NEUROSES^0.6048^3.1^4.3
 ;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.6676^3.1^4.4
 ;;883^19^MED^DISORDERS OF PERSONALITY & IMPULSE CONTROL^1.1188^4.9^8.2
 ;;884^19^MED^ORGANIC DISTURBANCES & MENTAL RETARDATION^0.9452^4.2^5.6
 ;;885^19^MED^PSYCHOSES^0.8899^5.5^7.5
 ;;886^19^MED^BEHAVIORAL & DEVELOPMENTAL DISORDERS^0.7895^3.7^6
 ;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^0.8336^3.1^4.7
 ;;894^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.4021^2.1^2.9
 ;;895^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY^0.9742^8.2^10.6
 ;;896^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC^1.4155^4.9^6.8
 ;;897^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC^0.6288^3.2^4
 ;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W MCC^4.0545^10^15
 ;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W CC^1.785^5.7^8
 ;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W/O CC/MCC^1.0137^3.3^4.5
 ;;904^21^SURG^SKIN GRAFTS FOR INJURIES W CC/MCC^2.8601^7.3^11.3
 ;;905^21^SURG^SKIN GRAFTS FOR INJURIES W/O CC/MCC^1.0901^3.4^4.6
 ;;906^21^SURG^HAND PROCEDURES FOR INJURIES^0.9991^2.1^3.1
 ;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W MCC^3.8072^8.1^11.6
 ;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W CC^1.8736^4.7^6.5
 ;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W/O CC/MCC^1.1135^2.6^3.4
 ;;913^21^MED^TRAUMATIC INJURY W MCC^1.3473^4.2^6
 ;;914^21^MED^TRAUMATIC INJURY W/O MCC^0.6789^2.6^3.4
 ;;915^21^MED^ALLERGIC REACTIONS W MCC^1.2545^3.3^4.6
 ;;916^21^MED^ALLERGIC REACTIONS W/O MCC^0.4513^1.7^2.1
 ;;917^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W MCC^1.4449^3.7^5.2
 ;;918^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W/O MCC^0.5839^2^2.7
 ;;919^21^MED^COMPLICATIONS OF TREATMENT W MCC^1.5883^4.4^6.3
 ;;920^21^MED^COMPLICATIONS OF TREATMENT W CC^0.9405^3.2^4.3
 ;;921^21^MED^COMPLICATIONS OF TREATMENT W/O CC/MCC^0.6121^2.3^2.8
 ;;922^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W MCC^1.3114^3.8^5.5
 ;;923^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W/O MCC^0.6556^2.3^3.2
 ;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV 96+ HRS W SKIN GRAFT^13.7351^24.4^32.7
 ;;928^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W CC/MCC^5.3052^11.7^16.4
 ;;929^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W/O CC/MCC^2.0086^5^7.4
 ;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV 96+ HRS W/O SKIN GRAFT^2.3081^2.4^5.7
 ;;934^22^MED^FULL THICKNESS BURN W/O SKIN GRFT OR INHAL INJ^1.3403^4.2^6.2
 ;;935^22^MED^NON-EXTENSIVE BURNS^1.2507^3.5^5.3
 ;;939^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W MCC^2.8593^7.2^10.9
 ;;940^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W CC^1.6821^3.5^5.7
 ;;941^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W/O CC/MCC^1.1298^2^2.6
 ;;945^23^MED^REHABILITATION W CC/MCC^1.2388^8.2^10
 ;;946^23^MED^REHABILITATION W/O CC/MCC^1.1159^6.7^7.7
 ;;947^23^MED^SIGNS & SYMPTOMS W MCC^1.0922^3.8^5.1
 ;;948^23^MED^SIGNS & SYMPTOMS W/O MCC^0.6689^2.8^3.5
 ;;949^23^MED^AFTERCARE W CC/MCC^0.9758^2.7^4.8
 ;;950^23^MED^AFTERCARE W/O CC/MCC^0.5459^2.5^3.4
 ;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.7239^2.1^4.2
 ;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^5.6781^8.9^12.8
 ;;956^24^SURG^LIMB REATTACHMENT, HIP & FEMUR PROC FOR MULTIPLE SIGNIFICANT TRAUMA^3.4364^7.3^9.1
 ;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W MCC^6.2993^10.5^15.1
 ;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W CC^3.6544^7.3^9.5
 ;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^2.2^4.5^5.8
 ;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W MCC^2.7687^6.2^9.2
 ;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W CC^1.5026^4.6^5.8
 ;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^0.9781^3.1^3.8
 ;;969^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W MCC^5.5074^13.2^18.8
 ;;970^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W/O MCC^2.5627^6.1^8.9
 ;;974^25^MED^HIV W MAJOR RELATED CONDITION W MCC^2.481^7.1^10
 ;;975^25^MED^HIV W MAJOR RELATED CONDITION W CC^1.3597^5.2^6.8
 ;;976^25^MED^HIV W MAJOR RELATED CONDITION W/O CC/MCC^0.8967^3.7^4.7
 ;;977^25^MED^HIV W OR W/O OTHER RELATED CONDITION^1.0538^3.7^5
 ;;981^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^5.0389^11.3^14.6
 ;;982^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.8954^7^9
 ;;983^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.8072^3.4^4.6
 ;;984^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.3443^11.7^14.6
 ;;985^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.9481^6.2^8.7
 ;;986^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.1079^2.9^4.3
 ;;987^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.402^9.4^12.6
 ;;988^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.7836^5.4^7.3
 ;;989^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.0358^2.6^3.7
 ;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0^0^0
 ;;999^99^**^UNGROUPABLE^0^0^0
 ;;EXIT
 Q
